Pharmaceutical Licensing Agreement Tombstone

Pharmaceutical Licensing Agreement Tombstone

Crystal tombstone commemorating an exclusive licensing agreement between Ovid Therapuetics and Angelini Pharma. The agreement centers on the development, manufacturing, and commercialization of a potential treatment for Angelman syndrome.

(20AJH130)